Identification of a FAS/FASL haplotype associated with endometriosis in Iranian patients

References

• Miller JE, Ahn SH, Monsanto SP, et al. Implications of immune dysfunction on endometriosis associated infertility. Oncotarget. 2017;8:7138.
   PubMedGoogle Scholar
• Shmueli A, Salman L, Hiersch L, et al. Obstetrical and neonatal outcomes of pregnancies complicated by endometriosis. J Maternal-Fetal Neonatal Med. 2019;32:845–850.
   PubMed Web of Science ®Google Scholar
• Pavone ME, Lyttle BM. Endometriosis and ovarian cancer: links, risks, and challenges faced. Int J Women's Health. 2015;7:663.
   PubMed Web of Science ®Google Scholar
• Jerzak M, Niemiec T, Nowakowska A, et al. First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles – case report. Am J Reprod Immunol. 2010;64:93–96.
   PubMed Web of Science ®Google Scholar
• Pollacco J, Sacco K, Portelli M, et al. Molecular links between endometriosis and cancer. Gynecol Endocrinol. 2012;28:577–581.
   PubMed Web of Science ®Google Scholar
• Vlahos NF, Kalampokas T, Fotiou S. Endometriosis and ovarian cancer: a review. Gynecol Endocrinol. 2010;26:213–219.
   PubMed Web of Science ®Google Scholar
• Burghaus S, Fasching PA, Häberle L, et al. Genetic risk factors for ovarian cancer and their role for endometriosis risk. Gynecol Oncol. 2017;145:142–147.
   PubMed Web of Science ®Google Scholar
• Oral E, Aydin O, Kumbak BA, et al. Concomitant endometriosis in malignant and borderline ovarian tumours. J Obstetr Gynaecol. 2018;38:1104–1109.
   PubMed Web of Science ®Google Scholar
• Wei C, Mei J, Tang L, et al. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489.
   PubMed Web of Science ®Google Scholar
• Králíčková M, Fiala L, Losan P, et al. Altered immunity in endometriosis: what came first? Immunol Invest. 2018;47:569–582.
   PubMed Web of Science ®Google Scholar
• Wu L, Lv C, Su Y, et al. Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol. Gynecol Endocrinol. 2019;35:251–256.
   PubMed Web of Science ®Google Scholar
• Fernandez R, Noval J, Garcia-Lozano J, et al. Polymorphisms in the promoter regions of FAS and FASL genes as candidate genetic factors conferring susceptibility to endometriosis. Int J Mol Med. 2005;15:865–869.
   PubMed Web of Science ®Google Scholar
• Li Y, Hao Y-L, Kang S, et al. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes. Gynecol Oncol. 2013;128:584–589.
   PubMed Web of Science ®Google Scholar
• Sbracia M, Valeri C, Antonini G, et al. Fas and Fas-ligand in eutopic and ectopic endometrium of women with endometriosis: the possible immune privilege of ectopic endometrium. Reprod Sci. 2016;23:81–86.
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh A, Pourfathollah AA, Tahoori MT, et al. Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients. Rheumatol Int. 2012;32:2833–2836.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang L-E, Sturgis EM, et al. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006;12:5596–5602.
   PubMed Web of Science ®Google Scholar
• Mogensen JB, Kjær SK, Mellemkjaer L, et al. Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study. Gynecol Oncol. 2016;143:87–92.
   PubMed Web of Science ®Google Scholar
• Chang HJ, Yoo J-Y, Kim TH, et al. Overexpression of Four Joint Box-1 Protein (FJX1) in eutopic endometrium from women with endometriosis. Reprod Sci. 2017;25;2:207–213.
   Google Scholar
• Mohammadzadeh A, Pourfathollah A, Sahraian MA, et al. Evaluation of apoptosis-related genes; Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients. J Neurol Sci. 2012;312:166–169.
   PubMed Web of Science ®Google Scholar
• Prodromidou A, Pergialiotis V, Pavlakis K, et al. A novel experimental model of colorectal endometriosis. J Invest Surg. 2018;31:275–281.
   PubMed Web of Science ®Google Scholar
• Tan SC, Ankathil R. Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes. Tumor Biol. 2015;36:6633–6644.
   PubMed Web of Science ®Google Scholar
• Wang W, Zheng Z, Yu W, et al. Polymorphisms of the FAS and FASL genes and risk of breast cancer. Oncol Lett. 2012;3:625–628.
   PubMed Web of Science ®Google Scholar
• Nair RR, Khanna A, Singh K. Association of FAS− 1377 G > A and FAS− 670 A > G functional polymorphisms of FAS gene of cell death pathway with recurrent early pregnancy loss risk. J Reproductive Immunol. 2012;93:114–118.
   PubMed Web of Science ®Google Scholar
• Nallapalle SR, Daripally S, Prasad V. Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently. Tumor Biol. 2015;36:2709–2724.
   PubMedGoogle Scholar
• Mohammadpour-Gharehbagh A, Salimi S, Keshavarzi F, et al. Association of FAS A-670G polymorphism and risk of uterine leiomyoma in a Southeast Iranian population. Rep Biochem Mol Biol. 2016;5:51.
   PubMed Web of Science ®Google Scholar
• Wang T, Lian Y. The relationship between Fas and Fas ligand gene polymorphism and preeclampsia risk. Biosci Rep. 2019;39:BSR20181901.
   PubMed Web of Science ®Google Scholar
• Pissetti CW, Tanaka S, Hortolani ACC, et al. Gene polymorphisms in FAS (Rs3740286 and Rs4064) are involved in endometriosis development in Brazilian women, but not those in CASP8 (rs13416436 and rs2037815). Rev Bras Ginecol Obstet. 2018;40:450–457.
   PubMedGoogle Scholar
• Zamani MR, Javan M. Immunological genetic variants underlying endometriosis. SAJ Genet. 2015;1:1.
   Google Scholar